Radiopharm Theranostics Limited American Depositary Shares (RADX PINK) stock market data APIs
$7.129
-0.08(-1.1%)
as of September 17, 2025
Try our APIs with
free plan!
Radiopharm Theranostics Limited American Depositary Shares Financial Data Overview
Price chart is built with
Anychart
Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It develops RAD 204, a programmed death-ligand 1 (PD-L1) for the treatment of non-small cell lung cancer (NSCLC); RAD 202, a human epidermal growth factor receptor 2 (HER2) to treat breast cancer and other solid tumors; and RAD 301, a diagnostic radiopharmaceutical targeting avß6 integrin in pancreatic ductal adenocarcinoma patients. The company also develops RAD 302, an avß6-integrin targeting agent for the treatment of multiple cancer types; RAD 101 and RAD 102 for brain metastases; RAD 402 to treat advanced prostate cancer; and RV01 for multiple solid tumors. It has strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.
Prev. Close
7.129
Open
7.0485
High
7.7348
Low
6.6032
52 wk Range
3.496-50.82
Market Cap
33 687 K
Shares Outstanding
7 780 K
Revenue
331 K
EPS
-1.96
Beta
0.801
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Radiopharm Theranostics Limited American Depositary Shares data using free add-ons & libraries
Get Radiopharm Theranostics Limited American Depositary Shares Fundamental Data
Radiopharm Theranostics Limited American Depositary Shares Fundamental data includes:
- Net Revenue: 331 K
- EBITDA: -32 993 392
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Radiopharm Theranostics Limited American Depositary Shares Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-08-29
- EPS/Forecast: 0
Get Radiopharm Theranostics Limited American Depositary Shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Radiopharm Theranostics Limited American Depositary Shares News
New
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
On track to complete enrollment of first two cohorts of RAD204 following positive recommendation from DSMC to escalate dose to 60mCi of Lu177 On track to complete enrollment of the first cohort of Ph...
Radiopharm Theranostics adds Dr Oliver Sartor to scientific advisory board
Radiopharm Theranostics Ltd (NASDAQ:RAD) announced Tuesday the appointment of Dr. Oliver Sartor to its Scientific Advisory Board. The company disclosed the appointment in a press release statement fur...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
